Sanjay Kaul

Active 1991–2025

69
Papers
24,836
Citations
58
h-index
67
i10-index

Citations

Citations per year for Sanjay Kaul1992: 2 citations1993: 2 citations1994: 1 citations1995: 3 citations1996: 6 citations1997: 4 citations1998: 7 citations1999: 17 citations2000: 28 citations2001: 60 citations2002: 64 citations2003: 101 citations2004: 116 citations2005: 119 citations2006: 104 citations2007: 136 citations2008: 143 citations2009: 113 citations2010: 127 citations2011: 126 citations2012: 135 citations2013: 137 citations2014: 141 citations2015: 123 citations2016: 102 citations2017: 102 citations2018: 123 citations2019: 453 citations2020: 550 citations2021: 783 citations2022: 660 citations2023: 494 citations2024: 806 citations2025: 363 citations2026: 11 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,743 citing papers, 20.3% of this breakdownUnited Kingdom: 1,069 citing papers, 7.9% of this breakdownGermany: 852 citing papers, 6.3% of this breakdownItaly: 798 citing papers, 5.9% of this breakdownCanada: 653 citing papers, 4.8% of this breakdownChina: 613 citing papers, 4.5% of this breakdownNetherlands: 595 citing papers, 4.4% of this breakdownFrance: 506 citing papers, 3.7% of this breakdownJapan: 426 citing papers, 3.2% of this breakdownSpain: 398 citing papers, 3% of this breakdownAustralia: 358 citing papers, 2.7% of this breakdownSwitzerland: 323 citing papers, 2.4% of this breakdown
0%20.3%Other 30.9%

Fields

  • Medicine83.4%
  • Biochemistry, Genetics and Molecular Biology5.9%
  • Immunology and Microbiology4.3%
  • Engineering1.9%
  • Nursing0.8%
  • Health Professions0.5%
  • Other3.2%

Topics

  • Diabetes Treatment and Management9.1%
  • Heart Failure Treatment and Management4.8%
  • Cardiovascular Function and Risk Factors4.3%
  • Coronary Interventions and Diagnostics3.8%
  • Acute Myocardial Infarction Research3.4%
  • Antiplatelet Therapy and Cardiovascular Diseases3.2%
  • Other71.4%

Coauthors

All papers

Open in search
  1. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Piotr Ponikowski, Naveed Sattar, Michele Senni, Marie‐France Seronde, Jindřich Špinar, Iain Squire, Stefano Taddei, Christoph Wanner, Faı̈ez Zannad - New England Journal of Medicine 2020 cited by 5,037

  2. Standardized Bleeding Definitions for Cardiovascular Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2011 cited by 4,423

  3. Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2021 cited by 192

  4. Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roland E. Schmieder, Christoph Wanner, Pantelis Sarafidis, Juliana C.N. Chan, László Rosivall, Joseph A. Eustace, Ehud Grossman, Yoram Yagil, Giuseppe Remuzzi, Daisuke Koya, Takashi Wada, Magdalena Madero Rovalo, Ron T. Gansevoort, Adriaan Kooy, Trine Finnes, Froilan DeLeon, Janusz Gumprecht, Fernando Teixeira e Costa, Alexander Dreval, Anantharaman Vathsala, Aslam Amod, Sin Gon Kim, Byung‐Wan Lee, Julio Pascual Santos, Bengt-Olov Tengmark, Michel Burnier, Chien‐Te Lee, Sukit Yamwong, Ramazan Sarı, Kieran McCafferty, Borys Mankovsky, Sharon G. Adler, Linda F. Fried, Mark V. Williams, Tran Quang Khanh, Diego Aizenberg, Inés Bartolacci, Diego Besada, Julio Bittar, Mariano Chahin, Alicia Elbert, Elizabeth Gelersztein, Alberto Liberman, Laura Maffei, Federico Pérez Manghi, Hugo Sanabria, Gloria Viñes, Alfredo Wassermann, Walter P. Abhayaratna, Shamasunder Acharya, Elif I. Ekinci, Darren Lee, Peak Mann Mah, Craig Nelson, David Packham, Alexia Pape, Simon Roger, Hugo Stephenson, Michael Suranyi, Gary Wittert, Elizabeth Vale, Martin Clodi, Christoph Ebenbichler, Evelyn Fließer-Görzer, Ursula Hanusch, Michael Krebs, Karl Lhotta, Bernhard Ludvik, Gert Mayer, Peter Neudorfer and 1,447 more - Annals of Internal Medicine 2023 cited by 88

  5. From Vulnerable Plaque to Vulnerable Patient

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wolfgang Köenig, Robert A. Lodder, Keith L. March, Jasenka Demirovic, Mohamad Navab, Silvia G. Priori, Mark D. Rekhter, Raymond D. Bahr, Scott M. Grundy, Roxana Mehran, Antonio Colombo, Eric Boerwinkle, Christie M. Ballantyne, William Insull, Robert S. Schwartz, Robert A. Vogel, Patrick W. Serruys, Göran K. Hansson, David P. Faxon, Sanjay Kaul, Helmut Drexler, Philip Greenland, James E. Muller, Renu Virmani, Paul M. Ridker, Douglas P. Zipes, Prediman K. Shah, James T. Willerson - Circulation 2003 cited by 2,671

  6. Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , - JAMA Cardiology 2023 cited by 60

  7. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2022 cited by 55

  8. Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert Forum

    Authors: , , , , , , , , , , , , - Diabetes Care 2017 cited by 369

  9. 2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 506

  10. Risk of Bias in Randomized Clinical Trials Comparing Transcatheter and Surgical Aortic Valve Replacement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Network Open 2023 cited by 58

  11. Impact of High Volume Energy Drink Consumption on Electrocardiographic and Blood Pressure Parameters: A Randomized Trial

    Authors: , , , , , , , , , , , , , - Journal of the American Heart Association 2019 cited by 110

  12. Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL

    Authors: , , , , , , , , , , , - Circulation 2001 cited by 667

  13. Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis

    Authors: , , - New England Journal of Medicine 2014 cited by 386

  14. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton consensus panel

    Authors: , , , , , , , , , , , , , , , - The American Journal of Cardiology 2000 cited by 395

  15. Dietary Intervention for Overweight and Obese Adults: Comparison of Low-Carbohydrate and Low-Fat Diets. A Meta-Analysis

    Authors: , , - PLoS ONE 2015 cited by 219

  16. The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience

    Authors: , , - New England Journal of Medicine 2013 cited by 204

  17. ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”

    Authors: , , , , , - Circulation 2010 cited by 357

  18. Oxidized Low-Density Lipoprotein Regulates Matrix Metalloproteinase-9 and Its Tissue Inhibitor in Human Monocyte-Derived Macrophages

    Authors: , , , , , , , - Circulation 1999 cited by 299

  19. ACCF/AHA New Insights Into the Methodology of Performance Measurement

    Authors: , , , , , , , , , , , - Circulation 2010 cited by 100

  20. Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2019 cited by 29

  21. ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jane A. Linderbaum, David J. Moliterno, Debabrata Mukherjee, Robert S. Rosenson, James H. Stein, Howard H. Weitz, Deborah J. Wesley - Journal of the American College of Cardiology 2012 cited by 406

  22. Trial and Error

    Authors: , - Journal of the American College of Cardiology 2010 cited by 270

  23. The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease

    Authors: , , , , , , , , , - European Heart Journal 2013 cited by 218

  24. Homocysteine Hypothesis for Atherothrombotic Cardiovascular Disease

    Authors: , , - Journal of the American College of Cardiology 2006 cited by 175